IXHL vs PATH · rev $86.0K vs P/E 19, rev $1.61B
Incannex Healthcare Ltd ADR (IXHL) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Incannex Healthcare Ltd ADR (IXHL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported IXHL revenue for 2025-03-31 was $86.0K. Net income was -$4.0M. IXHL currently screens at market cap $44.3M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
IXHL currently screens at market cap $44.3M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the IXHL and PATH stock pages for the full models.
Not investment advice.